细胞外组蛋白通过诱导外周血单个核细胞焦亡加重急性呼吸窘迫综合征
该研究纳入2019年4月至9月上海肺科医院20例ARDS患者和20名健康志愿者,检测血浆细胞外组蛋白、IL-1β、IL-18、LDH水平及PBMC中GSDMD-N蛋白表达。结果发现ARDS患者上述指标均显著高于健康对照,且GSDMD-N与PaO2/FiO2呈负相关(r=-0.935),与细胞外组蛋白等呈正相关。体外实验中,LPS刺激健康志愿者PBMC后加用外源性组蛋白可进一步上调GSDMD-N并促进炎症因子释放,而肝素可显著减轻这些效应。提示细胞外组蛋白可能通过介导PBMC焦亡加重ARDS。
要点
- ARDS患者PBMC中GSDMD-N蛋白表达显著高于健康对照[0.136(0.062, 0.246)vs. 0.026(0.018, 0.036),P<0.01]。
- ARDS患者血浆细胞外组蛋白显著升高[73.0(42.8, 112.9)mg/L vs. 12.2(9.6, 16.9)mg/L,P<0.01]。
- ARDS患者GSDMD-N蛋白表达与PaO2/FiO2呈负相关(r=-0.935,P<0.01)。
- 体外实验中肝素200 U处理24小时后,LPS+组蛋白组的GSDMD-N及IL-1β、IL-18、LDH均显著低于LPS+组蛋白组(均P<0.05)。
适用人群与场景
- 2019年4月至9月上海肺科医院收治的20例ARDS患者,诊断后24小时内采集外周血。
- 20名健康志愿者作为对照。
- 体外实验使用健康志愿者外周血分离的PBMC。
处置流程与药物剂量
- 体外实验分组处理:空白对照组不做任何处理;LPS组用1 mg/L LPS处理4小时;LPS+组蛋白组在LPS处理后用100 mg/L外源性组蛋白处理24小时;LPS+组蛋白+肝素组在LPS和外源性组蛋白处理后用200 U肝素处理24小时。
研究设计与关键结果
- 体内实验:ARDS患者PBMC中GSDMD-N蛋白表达显著高于健康对照[0.136(0.062, 0.246)vs. 0.026(0.018, 0.036),P<0.01]。
- 体内实验:ARDS患者血浆IL-1β、IL-18、LDH和细胞外组蛋白均显著高于健康对照[IL-1β(ng/L):120.0(94.2, 213.0)vs. 88.5(82.3, 105.3);IL-18(ng/L):164.5(70.8, 236.3)vs. 60.5(52.0, 89.0);LDH(U/L):30.9(24.7, 39.5)vs. 19.8(17.2, 21.5);细胞外组蛋白(mg/L):73.0(42.8, 112.9)vs. 12.2(9.6, 16.9),均P<0.01]。
- 体内实验:ARDS患者氧合指数(PaO2/FiO2)为135.5(94.5, 196.0)mmHg。
- 体内实验:ARDS患者GSDMD-N蛋白表达与PaO2/FiO2呈负相关(r=-0.935,P<0.01),与IL-1β、IL-18、LDH和细胞外组蛋白呈正相关(r值分别为0.844、0.843、0.887、0.899,均P<0.01)。
- 体外实验:与空白对照组比较,LPS组PBMC中GSDMD-N蛋白表达及上清炎症介质水平显著升高[GSDMD-N/GAPDH:0.035±0.006 vs. 0.028±0.006;IL-1β(ng/L):39.8±5.5 vs. 22.6±4.7;IL-18(ng/L):31.2±4.4 vs. 20.0±2.2;LDH(U/L):51.2±7.3 vs. 36.6±7.6,均P<0.05]。
- 体外实验:与LPS组比较,LPS+组蛋白组GSDMD-N蛋白表达及炎症介质水平进一步升高[GSDMD-N/GAPDH:0.114±0.009 vs. 0.035±0.006;IL-1β(ng/L):119.0±18.7 vs. 39.8±5.5;IL-18(ng/L):49.2±8.5 vs. 31.2±4.4;LDH(U/L):127.8±19.8 vs. 51.2±7.3,均P<0.01]。
- 体外实验:与LPS+组蛋白组比较,LPS+组蛋白+肝素组GSDMD-N蛋白表达及炎症介质水平显著降低[GSDMD-N/GAPDH:0.063±0.004 vs. 0.114±0.009;IL-1β(ng/L):46.8±8.6 vs. 119.0±18.7;IL-18(ng/L):33.0±5.1 vs. 49.2±8.5;LDH(U/L):65.4±11.0 vs. 127.8±19.8,均P<0.05]。
证据类型、等级与局限
- 研究类型:体内观察性比较(ARDS患者 vs. 健康对照)联合体外细胞实验。
- 样本量:ARDS患者20例,健康志愿者20名。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论认为血浆细胞外组蛋白可能通过介导PBMC焦亡加重ARDS。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore whether extracellular histones aggravate acute respiratory distress syndrome (ARDS) by inducing peripheral blood mononuclear cell (PBMC) pyroptosis.
METHODS: Twenty patients with ARDS admitted to Shanghai Pulmonary Hospital, Tongji University School of Medicine from April to September in 2019 were enrolled, and 20 healthy volunteers were enrolled as controls. In vivo experiment: peripheral blood samples of patients with ARDS within 24 hours after diagnosis and healthy volunteers were collected, and the levels of plasma extracellular histone, interleukins (IL-1β and IL-18) and lactic dehydrogenase (LDH) were determined by enzyme-linked immunosorbent assay (ELISA). PBMC were harvested, the expression levels of the pyroptosis associated N terminal-gasdermin-D (GSDMD-N) protein were determined by Western Blot. In vitro experiment: PBMC isolated from healthy volunteers were divided into four groups. Blank control group without any treatment; lipopolysaccharide (LPS) group was treated with 1 mg/L LPS for 4 hours; LPS+histones group was treated with 100 mg/L exogenous histones for 24 hours after LPS treatment; LPS+histone+heparin group was treated with 200 U heparin for 24 hours after LPS and exogenous histones treatment. The GSDMD-N protein expression was determined by Western Blot, and the levels of IL-1β, IL-18 and LDH in cell supernatant were determined by ELISA. Spearman test was used to test the correlation among the parameters.
RESULTS: In vivo experiment results: compared with healthy control group, the GSDMD-N protein expression in PBMC of patients with ARDS was significantly increased [GSDMD-N/GAPDH: 0.136 (0.062, 0.246) vs. 0.026 (0.018, 0.036), P < 0.01], as well as the plasma levels of IL-1β, IL-18, LDH and extracellular histones [IL-1β (ng/L): 120.0 (94.2, 213.0) vs. 88.5 (82.3, 105.3), IL-18 (ng/L): 164.5 (70.8, 236.3) vs. 60.5 (52.0, 89.0), LDH (U/L): 30.9 (24.7, 39.5) vs. 19.8 (17.2, 21.5), extracellular histones (mg/L): 73.0 (42.8, 112.9) vs. 12.2 (9.6, 16.9), all P < 0.01], indicating that the PBMC of ARDS patients had significant pyroptosis and release of a large number of inflammatory factors. The oxygenation index (PaO2/FiO2) of ARDS patients was 135.5 (94.5, 196.0) mmHg (1 mmHg = 0.133 kPa). Correlation analysis showed that the expression of GSDMD-N protein in patients with ARDS was negatively correlated with PaO2/FiO2 (r = -0.935, P < 0.01) and positively correlated with IL-1β, IL-18, LDH and extracellular histones (r value was 0.844, 0.843, 0.887, 0.899, respectively, all P < 0.01). In vitro experiment results: compared with blank control group, the expression of GSDMD-N protein in PBMC and the levels of inflammatory mediators in the supernatant of the LPS group were significantly increased [GSDMD-N/GAPDH: 0.035±0.006 vs. 0.028±0.006, IL-1β (ng/L): 39.8±5.5 vs. 22.6±4.7, IL-18 (ng/L): 31.2±4.4 vs. 20.0±2.2, LDH (U/L): 51.2±7.3 vs. 36.6±7.6, all P < 0.05], indicating that LPS stimulation could increase PBMC pyroptosis and the release of inflammatory mediators. Compared with LPS group, the expression of GSDMD-N protein and the levels of inflammatory mediators of the LPS+histones group were further increased [GSDMD-N/GAPDH: 0.114±0.009 vs. 0.035±0.006, IL-1β (ng/L): 119.0±18.7 vs. 39.8±5.5, IL-18 (ng/L): 49.2±8.5 vs. 31.2±4.4, LDH (U/L): 127.8±19.8 vs. 51.2±7.3, all P < 0.01], indicating that the stimulation of LPS on PBMC could be significantly amplified by exogenous histone treatment, GSDMD-N protein expression could be up-regulated and inflammatory factor release could be promoted to further induce PBMC pyroptosis. These adverse effects of exogenous histones on PBMC could be abrogated by heparin, the expression of GSDMD-N protein and the levels of inflammatory mediators were significantly lower than those of LPS+histones group [GSDMD-N/GAPDH: 0.063±0.004 vs. 0.114±0.009, IL-1β (ng/L): 46.8±8.6 vs. 119.0±18.7, IL-18 (ng/L): 33.0±5.1 vs. 49.2±8.5, LDH (U/L): 65.4±11.0 vs. 127.8±19.8, all P < 0.05].
CONCLUSIONS: Extracellular histones in plasma may aggravate ARDS by mediating PBMC pyroptosis.
参考来源
- Jin Y, Sun M, Jiang X, et al. [Extracellular histones aggravate acute respiratory distress syndrome by inducing peripheral blood mononuclear cells pyroptosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31898565. doi:10.3760/cma.j.issn.2095-4352.2019.11.009
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。